AHPA Responds to FDA Request on Botanical Drug Development

The American Herbal Products Association (AHPA) submitted comments to the U.S. Food and Drug Administration (FDA) in response to a request for information on the challenges and opportunities facing botanical drug development. In 2004, FDA published botanical drug guidance intended to facilitate the approval of over-the-counter (OTC) and prescription drug products derived from or consisting of botanicals. ...